Regarding the management and epidemiology of basal cell carcinoma, all of the following statements are correct EXCEPT:

Explanation

## Management and Epidemiology of Basal Cell Carcinoma ### Correct Statements (Options 0, 1, 3) **Key Point:** BCC management is stratified by risk; not all lesions require the same approach. | Aspect | Details | |--------|----------| | **Mohs Surgery** | Gold standard for high-risk BCC (face, ears, periocular, >2 cm, recurrent, aggressive histology); cure rate >95% | | **Adjuvant Therapy** | Radiotherapy indicated for perineural invasion, positive margins, recurrent disease, or advanced local invasion | | **Hedgehog Inhibitors** | Reserved for advanced/metastatic BCC or inoperable patients; NOT first-line for routine lesions | | **UV Risk** | UV-B (280–320 nm) is primary risk; cumulative exposure > intermittent sunburns | ### Why Option 2 Is Wrong **High-Yield:** Vismodegib and other Hedgehog pathway inhibitors (sonidegib) are NOT first-line treatment for all BCC lesions. They are reserved for: 1. **Advanced or metastatic BCC** (rare) 2. **Inoperable patients** (medical comorbidities, extensive disease) 3. **Gorlin syndrome** (multiple BCCs) Most BCC lesions are managed with surgical excision, Mohs surgery, cryotherapy, or topical agents (imiquimod, 5-FU) depending on size, location, and risk. **Warning:** Vismodegib is expensive, has significant side effects (muscle cramps, taste changes, alopecia), and is NOT indicated for routine, operable BCC. **Mnemonic: SHIM** — **S**urgery (first-line), **H**edgehog inhibitors (advanced/inoperable), **I**miquimod (small/low-risk), **M**ohs (high-risk). ### Risk Stratification ```mermaid flowchart TD A[BCC Diagnosis]:::outcome --> B{Risk Factors Present?}:::decision B -->|Low-risk| C[Size <2cm, trunk/extremities, no recurrence]:::outcome B -->|High-risk| D[Face, ears, >2cm, recurrent, aggressive histology]:::outcome C --> E[Simple excision, cryotherapy, or topical agents]:::action D --> F[Mohs micrographic surgery]:::action B -->|Advanced/Metastatic| G[Hedgehog inhibitor ± chemotherapy]:::action ``` ### Environmental Risk Factors **Clinical Pearl:** Cumulative UV-B exposure (occupational, outdoor workers) carries higher risk than intermittent intense exposure (vacations, sunburns). This explains why BCC is common in farmers, construction workers, and outdoor laborers.